| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.35 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |